Abstract: This invention relates to a process for removing metals, particularly mercury, from hydrocarbon streams by use of an ionic liquid, where in the metal-containing hydrocarbon stream is contacted with an ionic liquid to produce a product hydrocarbon stream having reduced mercury content.

Abstract: The present application relates to anti-LOX and anti-LOXL2 antibodies and their use in purification, diagnostic and therapeutic methods. Antibodies include monoclonal antibodies, humanized antibodies and functional fragments thereof. Anti-LOX and anti-LOXL2 antibodies can be used to identify and treat conditions such as a fibrotic condition, angiogenesis, or to prevent a transition from an epithelial cell state to a mesenchymal cell state.

Abstract: Mixtures of salts to dissolve cellulose. The present invention refers to a composition based in a eutectic mixture of imidazolium salts and natural biopolymers, in particular cellulose, its manufacturing process and method of use to obtain foils or films. The composition is based in a eutectic mixture of imidazolium salts with 0.1 to 50 wt % of biomass.

Abstract: Systems and methods are disclosed in which data associated with a transaction are protected with encryption. At an access device, a PIN associated with a payment account may be encrypted with a first key derived from an initial key of the access device and sensitive data associated with the payment account may be encrypted with a second key derived from the initial key. At a secure module associated with a host server encrypted sensitive data of an authorization request message may be decrypted. The secure module associated with the host server can re-encrypt the sensitive data using a zone encryption key associated with a payment processing network. A translated authorization request message including the re-encrypted sensitive data can be transmitted by the merchant server to the payment processing network.

Abstract: Examples disclosed herein relate to request authorization and authentication. Examples include to intercept a request from a processing pipeline of a device. The device to determine whether the request is authorized and authentic. The device to generate a cancellation request if the request is not authorized or not authenticated. The device to provide the cancellation request to the processing pipeline of the device.

Abstract: Systems and methods are disclosed in which data associated with a transaction are protected with encryption. At an access device, a PIN associated with a payment account may be encrypted with a first key derived from an initial key of the access device and sensitive data associated with the payment account may be encrypted with a second key derived from the initial key. At a secure module associated with a host server encrypted sensitive data of an authorization request message may be decrypted. The secure module associated with the host server can re-encrypt the sensitive data using a zone encryption key associated with a payment processing network. A translated authorization request message including the re-encrypted sensitive data can be transmitted by the merchant server to the payment processing network.

Abstract: Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.

Abstract: Methods and systems for an injection system are provided. An example injection system includes a container for a pharmaceutical that is sealed at a proximal end with a plunger having a pushing surface for engaging an inner surface of the hollow body. A plunger rod extends axially from the proximal end of the container and is covered with a plunger rod cover. Removal of the cover activates the system and allows for delivery of the pharmaceutical product from the container by advancing the plunger within the container towards the seal.

Abstract: Methods and systems for an injection system are provided. An example injection system includes a container for a pharmaceutical that is sealed at a proximal end with a plunger having a pushing surface for engaging an inner surface of the hollow body. A plunger rod extends axially from the proximal end of the container and is covered with a plunger rod cover. Removal of the cover activates the system and allows for delivery of the pharmaceutical product from the container by advancing the plunger within the container towards the seal.

Abstract: An under deck mid cabin entry system for a mono hull boat including an entry console disposed to the side of a center console and providing access to steps extending beneath the main deck. A top step is within the entry console proximate to the front surface and the steps curve towards a central beam of the boat and descend into the mid cabin such that a bottom step proximate to a floor of the mid cabin directs a user into a central area of the mid cabin and terminates to avoid obstructing movement in the central area. The bottom step further defines a landing platform for users of the boat.

Abstract: The invention relates to the use of a microorganism of the genus Brevibacterium for the biological degradation of ochratoxin A, in which the microorganism is preferably Brevibacterium casei, Brevibacterium linens, Brevibacterium iodinum or Brevibacterium epidermidis. In addition, the invention relates to a method for the production of ochratoxin ? using said microorganism.

Abstract: A caliper assembly (100) of a disc brake caliper, of the type with a modified braking action, comprising a caliper body (1) suitable to arrange astride of a brake disc, at least one first pad (8) being slidably received in at least one first seat (101) and so as to position itself between a first vehicle side elongated portion (5) and a first braking surface of the brake disk to abut, with a first pad plane (128) thereof, against said first braking surface (3) and to exert a braking action on the brake disc when pressed by the thrust means upon demand for a first friction action exerted by the first pad friction material against said first braking surface (3) causing a braking action, said assembly (100) further comprising a first insert (106) in a separate body from said caliper body (1) and in a separate body to said first pad (8) and particular in a separate body to said first pad plate (102), said first insert (106) comprises a balance wheel body (119) hinged to the caliper body (1) and oscillating in rel

Abstract: The motorized charcoal grill is a commercial grade transportable charcoal grill that is suitable for cooking large quantities of food. The motorized charcoal grill dedicates specific areas for automatic rotisseries, roasting racks, a side grill for quickly cooking small quantities and one or more ovens. The motorized charcoal grill is mounted on heavy duty casters so it can be moved easily. The motorized charcoal grill comprises a master pit, a side pit, a one or more ovens, a frame and a drive.

Abstract: Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.

Abstract: The present invention is a novel process for the preparation of chalcogenone compounds by conversion of ionic liquids and salts comprising nitrogen-containing heterocyclic cations and basic anions to the corresponding nitrogen-containing heterocyclic chalcogenones by reaction with elemental chalcogens.

Abstract: The present application relates to anti-LOX and anti-LOXL2 antibodies and their use in purification, diagnostic and therapeutic methods. Antibodies include monoclonal antibodies, humanized antibodies and functional fragments thereof. Anti-LOX and anti-LXL2 antibodies can be used to identify and treat conditions such as a fibrotic condition, angiogenesis, or to prevent a transition from an epithelial cell state to a mesenchymal cell state.